Celldex Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.1M | 51k | 41.97 |
| 2023-12-31 | $1.9M | 48k | 39.66 |
| 2023-09-30 | $1.1M | 41k | 27.52 |
| 2023-06-30 | $1.7M | 51k | 33.93 |
| 2023-03-31 | $1.3M | 36k | 35.98 |
| 2022-12-31 | $1.5M | 34k | 44.57 |
| 2022-09-30 | $961k | 34k | 28.14 |
| 2022-06-30 | $805k | 30k | 26.92 |
| 2022-03-31 | $984k | 29k | 34.02 |
| 2021-12-31 | $1.1M | 28k | 38.63 |
| 2021-09-30 | $1.6M | 30k | 53.83 |
| 2021-06-30 | $885k | 26k | 33.49 |
| 2021-03-31 | $907k | 49k | 18.52 |
| 2020-12-31 | $1.6M | 68k | 23.81 |
| 2020-03-31 | $59k | 35k | 1.66 |